30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: Baxano Surgical

$4.7MM, +20% (U.S. $4.5MM, +22%, ex-U.S. $0.2MM, flat)

  • Growth primarily attributed to increased cases per surgeon
  • Product line growth is reported as sequential from 1Q14.
  • iO-Flex $2.5MM (U.S. +6%), 16 new users (81 new customers over past 3 quarters)
  • AxiaLIF $1.4MM, +15% (U.S. +11%)
  • VEO $0.5MM, total users flat, cases per surgeon decreased
  • iO-Tome $0.1MM, flat
  • Commenced limited launch of Avance MIS pedicle screw, full release slated for 4Q, will offer bundled interbody fusion + posterior fixation
  • Not expecting to increase numbers in direct salesforce